WHO ICTRP trial
Efficacy of intravitreal methotrexate for intraocular lymphoma
JPRN-UMIN000004451 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000004451 |
|---|---|
| Public title | Efficacy of intravitreal methotrexate for intraocular lymphoma |
| Scientific title | Efficacy of intravitreal methotrexate for intraocular lymphoma - Intravitreal methotrexate for intraocular lymphoma |
| Primary sponsor | Institute of Health Biosiences, The University of Tokushima Graduate School |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Intraocular lymphoma |
| Interventions | Intravitreal methotrexate injection |
| Registration date | Jan 11, 2010 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: